Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

A new Lancet study warns liver cancer cases could nearly double by 2050, if no action is taken. The authors emphasise ...

Domestic researchers have found for the first time in the world that immuno-cancer drugs atetzolizumab plus bevacizumab ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

“There are a lot of treatment options depending on how bad your liver disease is, how many cancers in the liver you have, how ...

This review explores the dynamic landscape of hepatocellular carcinoma (HCC) treatment, emphasizing on recent developments across various stages and therapeutic approaches. Although curative ...

Hepatitis B vaccination stands as a powerful tool against liver cancer, particularly hepatocellular carcinoma, by preventing ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the fourth most common cause of cancer-related death worldwide. 1 In 2017, there were an estimated 953,000 incident cases of liver ...